MetaCap

Who Owns Atea Pharmaceuticals Stock?

NASDAQ: AVIRHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.96+0.03 (+0.76%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
78.47%
Institutional holders
183
  • Institutions 78.5%
  • Insiders 13.4%
  • Public and other 8.2%

Who owns Atea Pharmaceuticals stock?

Institutional investors own about 78.5% of Atea Pharmaceuticals's shares, spread across 183 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 13.35% of AVIR.

The largest institutional holders are FMR, LLC (14.98%), Blackrock Inc. (11.28%) and BML Capital Management, LLC (8.41%). Together, the top 10 institutions control 55.8% of shares outstanding. In their latest filings, 3 of the top 10 institutions increased their AVIR positions and 5 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of AVIR

Atea Pharmaceuticals top institutional holders
InstitutionShares% HeldChange
FMR, LLC12.03M14.98%+0.2%
Blackrock Inc.9.06M11.28%+3.9%
BML Capital Management, LLC6.75M8.41%-2.9%
Tang Capital Management, LLC4.81M6.00%0.0%
Vanguard Capital Management LLC2.91M3.62%-2.0%
Acadian Asset Management. LLC2.34M2.91%+14.9%
Bain Capital Life Sciences Investors, LLC2.08M2.58%0.0%
Geode Capital Management, LLC1.91M2.38%-2.5%
State Street Corporation1.63M2.03%-1.5%
Two Sigma Investments, LP1.30M1.62%-13.5%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of AVIR

Atea Pharmaceuticals top fund holders
FundShares% Held
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund3.13M3.89%
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.03M2.53%
iShares Trust-iShares Russell 2000 ETF1.84M2.30%
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund1.22M1.52%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund865.32K1.08%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund777.40K0.97%
Fidelity Mt. Vernon Street Trust-Fidelity Series Growth Company Fund733.90K0.91%
iShares Trust-iShares Russell 2000 Value ETF672.54K0.84%
BlackRock Funds-BlackRock Advantage Small Cap Core Fund613.37K0.76%
iShares Trust-iShares Biotechnology ETF504.71K0.63%

Frequently asked questions

Who is the largest shareholder of Atea Pharmaceuticals?

FMR, LLC is the largest institutional shareholder of AVIR, owning 14.98% of shares outstanding (12.03M shares) as of its latest 13F filing.

What percentage of Atea Pharmaceuticals is owned by institutions?

Institutions own about 78.5% of AVIR shares and 90.6% of the public float.

How much of Atea Pharmaceuticals do insiders own?

Insiders, such as officers and directors, own about 13.35% of AVIR shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related